{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:48:50Z","timestamp":1791139730213,"version":"4.1.0"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T00:00:00Z","timestamp":1320710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T00:00:00Z","timestamp":1320710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1038\/nrgastro.2011.174","type":"journal-article","created":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T10:58:45Z","timestamp":1320749925000},"page":"701-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["New-generation vaccines against cholera"],"prefix":"10.1038","volume":"8","author":[{"given":"John","family":"Clemens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunheang","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipika","family":"Sur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Balakrish","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Holmgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,8]]},"reference":[{"key":"BFnrgastro2011174_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0140-6736(03)15328-7","volume":"363","author":"DA Sack","year":"2004","unstructured":"Sack, D. A., Sack, R. B., Nair, G. B. & Siddique, A. K. Cholera. Lancet 363, 223\u2013233 (2004).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR2","unstructured":"World Health Organization. Cholera. Weekly Epidemiological Record. 85, 293\u2013308 (2010)."},{"key":"BFnrgastro2011174_CR3","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/S0140-6736(10)62172-1","volume":"376","author":"JB Harris","year":"2010","unstructured":"Harris, J. B.  et al. Cholera's western front. Lancet 376, 1961\u20131965 (2010).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1056\/NEJMp0810559","volume":"360","author":"E Mintz","year":"2009","unstructured":"Mintz, E. & Guerrant, R. A lion in our village\u2014the unconscionable tragedy of cholera in Africa. N. Engl. J. Med. 360, 1060\u20131063 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2011174_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/oxfordjournals.aje.a113498","volume":"116","author":"RI Glass","year":"1982","unstructured":"Glass, R. I.  et al. Endemic cholera in Bangladesh, 1966\u20131980. Am. J. Epidemiol. 116, 959\u2013970 (1982).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrgastro2011174_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1365-2958.2005.04676.x","volume":"57","author":"SM McCleod","year":"2005","unstructured":"McCleod, S. M., Kimsey, H. H., Davis, B. M. & Waldor, M. K. CTX\u03c6 and Vibrio cholerae: exploring a newly recognized type of phage\u2013host cell relationship. Mol. Microbiol. 57, 347\u2013366 (2005).","journal-title":"Mol. Microbiol."},{"key":"BFnrgastro2011174_CR7","first-page":"342","volume":"96","author":"W Woodward","year":"1972","unstructured":"Woodward, W. & Mosley, W. H. The spectrum of cholera in rural Bangladesh. II. Comparison of El Tor Ogawa and classical Inaba infections. J. Infect. Dis. 96, 342\u2013351 (1972).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR8","unstructured":"Pollitzer, R. Cholera. Geneva. World Health Organization. (1959)."},{"key":"BFnrgastro2011174_CR9","first-page":"9","volume-title":"Vibrio cholerae and Cholera","author":"D Barua","year":"1988","unstructured":"Barua, D. in Vibrio cholerae and Cholera (ed. Takeda, Y.) 9\u201332 (KTK Scientific Publishers, Tokyo, 1988)."},{"key":"BFnrgastro2011174_CR10","first-page":"561","volume":"64","author":"H Felix","year":"1971","unstructured":"Felix, H. The development of the cholera epidemic in West Africa. Bull. Soc. Pathol. Exot Filiales. 64, 561\u2013582 (1971).","journal-title":"Bull. Soc. Pathol. Exot Filiales."},{"key":"BFnrgastro2011174_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7326\/0003-4819-82-1-101","volume":"82","author":"R Goodgame","year":"1975","unstructured":"Goodgame, R. & Greenough, W. Cholera in Africa. Ann. Intern. Med. 82, 101\u2013106 (1975).","journal-title":"Ann. Intern. Med."},{"key":"BFnrgastro2011174_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/oxfordjournals.aje.a112391","volume":"105","author":"PA Blake","year":"1977","unstructured":"Blake, P. A.  et al. Cholera in Portugal, 1974. I. Modes of transmission. Am. J. Epidemiol. 105, 337\u2013343 (1977).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrgastro2011174_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4269\/ajtmh.1993.48.597","volume":"93","author":"RE Quick","year":"1993","unstructured":"Quick, R. E.  et al. Epidemic cholera in the Amazon: the challenge of preventing death. Am. J. Trop. Med. Hyg. 93, 597\u2013602 (1993).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnrgastro2011174_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/0140-6736(92)92432-F","volume":"340","author":"DL Swerdlow","year":"1992","unstructured":"Swerdlow, D. L.  et al. Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk. Lancet 340, 28\u201332 (1992).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR15","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/0140-6736(93)90855-B","volume":"341","author":"MK Bhattacharya","year":"1993","unstructured":"Bhattacharya, M. K.  et al. Outbreak of Vibrio cholerae non-O1 in India and Bangladesh. Lancet 341, 1346\u20131347 (1993).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR16","first-page":"108","volume":"27","author":"S Garg","year":"1993","unstructured":"Garg, S.  et al. Nationwide prevalence of the new epidemic strain of Vibrio cholerae O139 Bengal in India. J. Infect. Dis. 27, 108\u2013109 (1993).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR17","doi-asserted-by":"crossref","unstructured":"Cholera Working Group. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Lancet 342, 387\u2013390 (1992).","DOI":"10.1016\/0140-6736(93)92811-7"},{"key":"BFnrgastro2011174_CR18","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/infdis\/171.4.903","volume":"171","author":"JG Morris","year":"1995","unstructured":"Morris, J. G.  et al. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers. J. Infect. Dis. 171, 903\u2013908 (1995).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR19","first-page":"33","volume":"38","author":"GB Nair","year":"1994","unstructured":"Nair, G. B., Bhattacharya, S. & Deb, B. Vibrio cholerae O139 Bengal: the eighth pandemic strain of cholera. Indian J. Public Health 38, 33\u201336 (1994).","journal-title":"Indian J. Public Health"},{"key":"BFnrgastro2011174_CR20","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1128\/JCM.40.9.3296-3299.2002","volume":"40","author":"GB Nair","year":"2002","unstructured":"Nair, G. B.  et al. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J. Clin. Microbiol. 40, 3296\u20133299 (2002).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrgastro2011174_CR21","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.3201\/eid1011.040682","volume":"10","author":"M Ansaruzzaman","year":"2004","unstructured":"Ansaruzzaman, M.  et al. The Mozambique Cholera Vaccine Demonstration. Project Coordination Group. Cholera in Mozambique, Variant of Vibrio cholerae. Emerg. Infect. Dis. 10, 2057\u20132059 (2004).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrgastro2011174_CR22","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1128\/JCM.01304-06","volume":"23","author":"GB Nair","year":"2006","unstructured":"Nair, G. B.  et al. Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh. J. Clin. Microbiol. 23, 4211\u20134213 (2006).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrgastro2011174_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3201\/eid1501.080543","volume":"15","author":"A Taychoudhuri","year":"2009","unstructured":"Taychoudhuri, A.  et al. Classical ctxB in Vibrio cholerae O1, Kolkata, India. Emerg. Infect. Dis. 15, 131\u2013132 (2009).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrgastro2011174_CR24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3201\/eid1406.080129","volume":"14","author":"A Safa","year":"2008","unstructured":"Safa, A., Sultana, J., Dac Cam, P., Mwansa, J. C. & Kong, R. Y. Vibrio cholerae O1 hybrid El Tor strains, Asia and Africa. Emerg. Infect. Dis. 14, 987\u2013988 (2008).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrgastro2011174_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa1012928","volume":"364","author":"CS Chin","year":"2011","unstructured":"Chin, C. S.  et al. The origin of Haitian cholera outbreak strain. N. Engl. J. Med. 364, 33\u201342 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2011174_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1017\/S0950268809990550","volume":"138","author":"A Siddique","year":"2010","unstructured":"Siddique, A.  et al. El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol. Infect. 138, 347\u2013352 (2010).","journal-title":"Epidemiol. Infect."},{"key":"BFnrgastro2011174_CR27","first-page":"1192","volume":"47","author":"CC Carpenter","year":"1971","unstructured":"Carpenter, C. C. Cholera: diagnosis and treatment. Bull. NY Acad. Med. 47, 1192\u20131203 (1971).","journal-title":"Bull. NY Acad. Med."},{"key":"BFnrgastro2011174_CR28","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/0035-9203(89)90348-9","volume":"83","author":"T Butler","year":"1989","unstructured":"Butler, T., Arnold, M. & Islam, M. Depletion of hepatic glycogen in the hypoglycaemia of fatal childhood diarrhoeal illnesses. Trans. R. Soc. Trop. Med. Hyg. 83, 839\u2013843 (1989).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"BFnrgastro2011174_CR29","first-page":"35","volume":"83","author":"M Khan","year":"1980","unstructured":"Khan, M. & Shahidullah, M. Cholera due to the E1 Tor biotype equals the classical biotype in severity and attack rates. J. Trop. Med. Hyg. 83, 35\u201339 (1980).","journal-title":"J. Trop. Med. Hyg."},{"key":"BFnrgastro2011174_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1128\/9781555818364.ch28","volume-title":"Vibrio cholerae and Cholera: Molecular to Global Perspectives","author":"J Clemens","year":"1994","unstructured":"Clemens, J., Spriggs, D. & Sack, D. in Vibrio cholerae and Cholera: Molecular to Global Perspectives (ed. Wachsmith, I. K., Blake, P. & Olsvik, O.) 425\u2013440 (American Society for Microbiology, Washington, 1994)."},{"key":"BFnrgastro2011174_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJM198002073020601","volume":"302","author":"PA Blake","year":"1980","unstructured":"Blake, P. A.  et al. Cholera\u2014a possible endemic focus in the United States. N. Engl. J. Med. 302, 305\u2013309 (1980).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2011174_CR32","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0140-6736(76)90915-6","volume":"2","author":"DR Nalin","year":"1976","unstructured":"Nalin, D. R. Cholera, copepods, and chitinase. Lancet 2, 958 (1976).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/aem.52.3.586-588.1986","volume":"52","author":"A Huq","year":"1986","unstructured":"Huq, A.  et al. Colonization of the gut of the blue crab (Callinectes sapidus) by Vibrio cholerae. Appl. Environ. Microbiol. 52, 586\u2013588 (1986).","journal-title":"Appl. Environ. Microbiol."},{"key":"BFnrgastro2011174_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0303-2647(93)90050-M","volume":"31","author":"PR Epstein","year":"1993","unstructured":"Epstein, P. R. Algal blooms in the spread and persistence of cholera. Biosystems 31, 209\u2013221 (1993).","journal-title":"Biosystems"},{"key":"BFnrgastro2011174_CR35","first-page":"396","volume":"92","author":"MS Islam","year":"1989","unstructured":"Islam, M. S., Drasar, B. S. & Bradley, D. J. Attachment of toxigenic Vibrio cholerae O1 to various freshwater plants and survival with a filamentous green alga, Rhizoclonium fontanum. J. Trop. Med. Hyg. 92, 396\u2013401 (1989).","journal-title":"J. Trop. Med. Hyg."},{"key":"BFnrgastro2011174_CR36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1128\/aem.45.1.275-283.1983","volume":"45","author":"A Huq","year":"1983","unstructured":"Huq, A.  et al. Ecological relationships between Vibrio cholerae and planktonic crustacean copepods. Appl. Environ. Microbiol. 45, 275\u2013283 (1983).","journal-title":"Appl. Environ. Microbiol."},{"key":"BFnrgastro2011174_CR37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/aem.48.2.420-424.1984","volume":"48","author":"A Huq","year":"1984","unstructured":"Huq, A., West, P. A., Small, E. B., Huq, M. I. & Colwell, R. R. Influence of water temperature, salinity, and pH on survival and growth of toxigenic Vibrio cholerae serovar O1 associated with live copepods in laboratory microcosms. Appl. Environ. Microbiol. 48, 420\u2013424 (1984).","journal-title":"Appl. Environ. Microbiol."},{"key":"BFnrgastro2011174_CR38","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nature00778","volume":"417","author":"DS Merrell","year":"2002","unstructured":"Merrell, D. S.  et al. Host-induced epidemic spread of the cholera bacterium. Nature 417, 642\u2013645 (2002).","journal-title":"Nature"},{"key":"BFnrgastro2011174_CR39","doi-asserted-by":"publisher","first-page":"6674","DOI":"10.1128\/IAI.73.10.6674-6679.2005","volume":"73","author":"A Alam","year":"2005","unstructured":"Alam, A.  et al. Hyperinfectivity of human-passaged Vibrio cholerae can be modeled by growth in the infant mouse. Infect. Immun. 73, 6674\u20136679 (2005).","journal-title":"Infect. Immun."},{"key":"BFnrgastro2011174_CR40","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0140-6736(78)91569-6","volume":"2","author":"DR Nalin","year":"1978","unstructured":"Nalin, D. R.  et al. Cannabis, hypochlorhydria, and cholera. Lancet 2, 859\u2013862 (1978).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR41","first-page":"31","volume":"47","author":"GH Sack Jr","year":"1972","unstructured":"Sack, G. H. Jr  et al. Gastric acidity in cholera and noncholera diarrhoea. Bull. World Health Organ. 47, 31\u201336 (1972).","journal-title":"Bull. World Health Organ."},{"key":"BFnrgastro2011174_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1369-5274(02)00285-0","volume":"5","author":"DS Merrell","year":"2002","unstructured":"Merrell, D. S. & Camilli, A. Acid tolerance of gastrointestinal pathogens. Curr. Opin. Microbiol. 5, 51\u201355 (2002).","journal-title":"Curr. Opin. Microbiol."},{"key":"BFnrgastro2011174_CR43","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/oxfordjournals.aje.a115515","volume":"131","author":"JD Clemens","year":"1990","unstructured":"Clemens, J. D.  et al. Breast feeding and the risk of severe cholera in rural Bangladeshi children. Am. J. Epidemiol. 131, 400\u2013411 (1990).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrgastro2011174_CR44","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1056\/NEJM198306093082304","volume":"308","author":"RI Glass","year":"1983","unstructured":"Glass, R. I.  et al. Protection against cholera in breast-fed children by antibodies in breast milk. N. Engl. J. Med. 308, 1389\u20131392 (1983).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2011174_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/03014468100005061","volume":"8","author":"BK Sircar","year":"1981","unstructured":"Sircar, B. K.  et al. ABO blood group distributions in diarrhoea cases including cholera in Calcutta. Ann. Hum. Biol. 8, 289\u2013291 (1981).","journal-title":"Ann. Hum. Biol."},{"key":"BFnrgastro2011174_CR46","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/0035-9203(87)90302-6","volume":"81","author":"RE Black","year":"1987","unstructured":"Black, R. E., Levine, M. M., Clements, M. L., Hughes, T. & O'Donnell, S. Association between O blood group and occurrence and severity of diarrhoea due to Escherichia coli. Trans. R. Soc. Trop. Med. Hyg. 81, 120\u2013123 (1987).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"BFnrgastro2011174_CR47","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/infdis\/159.4.770","volume":"159","author":"JD Clemens","year":"1989","unstructured":"Clemens, J. D.  et al. ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy. J. Infect. Dis. 159, 770\u2013773 (1989).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0016-5085(85)90741-3","volume":"89","author":"J Holmgren","year":"1985","unstructured":"Holmgren, J., Lindblad, M., Fredman, P., Svennerholm, L. & Myrvold, H. Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine. Gastroenterology 89, 27\u201335 (1985).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2011174_CR49","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/oxfordjournals.aje.a114050","volume":"121","author":"RI Glass","year":"1985","unstructured":"Glass, R. I.  et al. Predisposition for cholera of individuals with O blood group: possible evolutionary significance. Am. J. Epidemiol. 121, 791\u2013796 (1985).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrgastro2011174_CR50","doi-asserted-by":"publisher","first-page":"7422","DOI":"10.1128\/IAI.73.11.7422-7427.2005","volume":"73","author":"JB Harris","year":"2005","unstructured":"Harris, J. B.  et al. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect. Immun. 73, 7422\u20137427 (2005).","journal-title":"Infect. Immun."},{"key":"BFnrgastro2011174_CR51","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1128\/IAI.66.2.692-695.1998","volume":"66","author":"CO Tacket","year":"1998","unstructured":"Tacket, C. O.  et al. Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection. Infect. Immun. 66, 692\u2013695 (1998).","journal-title":"Infect. Immun."},{"key":"BFnrgastro2011174_CR52","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1073\/pnas.84.9.2833","volume":"84","author":"RK Taylor","year":"1987","unstructured":"Taylor, R. K., Miller, V. L., Furlong, D. B. & Mekalanos, J. J. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc. Natl Acad. Sci. USA 84, 2833\u20132837 (1987).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2011174_CR53","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1128\/IAI.74.4.2072-2079.2006","volume":"74","author":"AJ Silva","year":"2006","unstructured":"Silva, A. J., Leitch, G. J., Camilli, A. & Benitez, J. A. Contribution of hemeagglutinin\/protease and motility to pathogenesis of El Tor biotype cholera. Infect. Immun. 74, 2072\u20132079 (2006).","journal-title":"Infect. Immun."},{"key":"BFnrgastro2011174_CR54","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrmicro1207","volume":"3","author":"S Butler","year":"2005","unstructured":"Butler, S. & Camilli, A. Going against the grain: chemotaxis and infection in Vibrio cholerae. Nat. Rev. Microbiol. 3, 611\u2013620 (2005).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFnrgastro2011174_CR55","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0092-8674(00)81551-2","volume":"99","author":"SH Lee","year":"1999","unstructured":"Lee, S. H., Hava, D. L., Waldor, M. K. & Camilli, A. Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection. Cell 99, 625\u2013634 (1999).","journal-title":"Cell"},{"key":"BFnrgastro2011174_CR56","first-page":"448","volume":"79","author":"J Holmgren","year":"1971","unstructured":"Holmgren, J., Lonnroth, I. & Ouchterlony, O. Identification and characterization of cholera exotoxin in culture filtrates of V. cholerae. Acta Pathol. Microbiol Scand. [B] Microbiol. Immunol. 79, 448 (1971).","journal-title":"Acta Pathol. Microbiol Scand. [B] Microbiol. Immunol."},{"key":"BFnrgastro2011174_CR57","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1099\/00221287-76-2-417","volume":"76","author":"I Lonnroth","year":"1973","unstructured":"Lonnroth, I. & Holmgren, J. Subunit structure of cholera toxin. J. Gen. Microbiol. 76, 417\u2013427 (1973).","journal-title":"J. Gen. Microbiol."},{"key":"BFnrgastro2011174_CR58","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/inf.1973.5.issue-1.15","volume":"5","author":"J Holmgren","year":"1973","unstructured":"Holmgren, J., Lonnroth, I. & Svennerholm, L. Fixation and inactivation of cholera toxin by GM1 ganglioside. Scand. J. Infect. Dis. 5, 77\u201378 (1973).","journal-title":"Scand. J. Infect. Dis."},{"key":"BFnrgastro2011174_CR59","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1172\/JCI106599","volume":"50","author":"DV Kimberg","year":"1971","unstructured":"Kimberg, D. V., Field, M., Johnson, J., Henderson, A. & Gershon, E. Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins. J. Clin. Invest. 50, 1218\u20131230 (1971).","journal-title":"J. Clin. Invest."},{"issue":"Suppl.","key":"BFnrgastro2011174_CR60","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1093\/infdis\/136.Supplement.S105","volume":"136","author":"J Holmgren","year":"1977","unstructured":"Holmgren, J. & Svennerholm, A. M. Mechanisms of disease and immunity in cholera: a review. J. Infect. Dis. 136 (Suppl.), S105\u2013S112 (1977).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR61","first-page":"106","volume":"22","author":"J Holmgren","year":"1983","unstructured":"Holmgren, J. & Svennerholm, A. M. Cholera and the immune response. Prog. Allergy 22, 106\u2013119 (1983).","journal-title":"Prog. Allergy"},{"key":"BFnrgastro2011174_CR62","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","volume":"158","author":"J Clemens","year":"1988","unstructured":"Clemens, J.  et al. Cross-protection by B subunit-killed whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J. Infect. Dis. 158, 372\u2013377 (1988).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR63","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/infdis\/169.3.709","volume":"169","author":"MJ Albert","year":"1994","unstructured":"Albert, M. J., Alam, K., Rahman, A. S., Huda, S. & Sack, R. B. Lack of cross-protection against diarrhea due to Vibrio cholerae O1 after oral immunization of rabbits with, V. cholerae O139 Bengal. J. Infect. Dis. 169, 709\u2013710 (1994).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR64","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/infdis\/jir416","volume":"204","author":"M Ali","year":"2011","unstructured":"Ali, M., Emch, M., Park, J. K., Yunus, M. & Clemens, J. Natural cholera infection-derived immunity in an endemic setting. J. Infect. Dis. 204, 912\u2013918 (2011).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR65","first-page":"381","volume":"49","author":"WH Mosley","year":"1973","unstructured":"Mosley, W. H., Aziz, K. M., Rahman, A. S., Chowdhury, A. K. & Ahmed, A. Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh\u2014three years of observation. Bull. World Health Organ. 49, 381\u2013387 (1973).","journal-title":"Bull. World Health Organ."},{"key":"BFnrgastro2011174_CR66","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1086\/341206","volume":"186","author":"IM Longini Jr","year":"2002","unstructured":"Longini, I. M. Jr  et al. Epidemic and endemic cholera trends over a 33-year period in Bangladesh. J. Infect. Dis. 186, 246\u2013251 (2002).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR67","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/jhmas\/XXXVII.4.399","volume":"37","author":"GH Bornside","year":"1982","unstructured":"Bornside, G. H. Waldemar Haffkine's cholera vaccines and the Ferran\u2013Haffkine priority dispute. J. Hist. Med. Allied Sci. 37, 399\u2013422 (1982).","journal-title":"J. Hist. Med. Allied Sci."},{"key":"BFnrgastro2011174_CR68","first-page":"153","volume":"35","author":"C Chandrasekar","year":"1947","unstructured":"Chandrasekar, C. Statistical assessment of the efficacy of anti-cholera inoculation from the data of 63 cheris in south Sercot district. Indian J. Med. Res. 35, 153 (1947).","journal-title":"Indian J. Med. Res."},{"key":"BFnrgastro2011174_CR69","first-page":"333","volume-title":"Cholera","author":"I Joo","year":"1974","unstructured":"Joo, I. Cholera (eds Barua, D. & Burrows, W.) 333\u2013349 (Saunders, Philadelphia, 1974)."},{"key":"BFnrgastro2011174_CR70","first-page":"347","volume":"38","author":"AS Benenson","year":"1968","unstructured":"Benenson, A. S., Joseph, P. R. & Oseasohn, R. O. Cholera vaccine field trials in east Pakistan. 1. Reaction and antigenicity studies. Bull. World Health Organ. 38, 347\u2013357 (1968).","journal-title":"Bull. World Health Organ."},{"key":"BFnrgastro2011174_CR71","unstructured":"World Health Organization and Global Task Force on Cholera Control. Guidelines for Cholera Control. Geneva: World Health Organization. (1994)."},{"key":"BFnrgastro2011174_CR72","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/infdis\/130.4.325","volume":"130","author":"RA Cash","year":"1974","unstructured":"Cash, R. A.  et al. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine. J. Infect. Dis. 130, 325\u2013333 (1974).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR73","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/0140-6736(91)90207-6","volume":"337","author":"JD Clemens","year":"1991","unstructured":"Clemens, J. D.  et al. Biotype as determinant of natural immunising effect of cholera. Lancet 337, 883\u2013884 (1991).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR74","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/infdis\/149.6.884","volume":"149","author":"AM Svennerholm","year":"1984","unstructured":"Svennerholm, A. M.  et al. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J. Infect. Dis. 149, 884\u2013893 (1984).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR75","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/cid\/cir141","volume":"52","author":"S Shin","year":"2011","unstructured":"Shin, S., Desai, S., Sah, B. K. & Clemens, J. Oral vaccines against cholera. Clin. Infect. Dis. 52, 1343\u20131349 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrgastro2011174_CR76","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/0264-410X(92)90324-D","volume":"10","author":"J Holmgren","year":"1992","unstructured":"Holmgren, J.  et al. An oral B subunit: whole cell vaccine against cholera. Vaccine 10, 911\u2013914 (1992).","journal-title":"Vaccine"},{"key":"BFnrgastro2011174_CR77","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/infdis\/154.1.175","volume":"154","author":"J Clemens","year":"1986","unstructured":"Clemens, J.  et al. Effect of neutralization of gastric acid on immune responses to oral B subunit killed whole cell cholera vaccine. J. Infect. Dis. 154, 175\u2013178 (1986).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR78","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/iai.13.3.735-740.1976","volume":"13","author":"AM Svennerholm","year":"1976","unstructured":"Svennerholm, A. M. & Holmgren, J. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin\/toxoid. Infect. Immun. 13, 735\u2013740 (1976).","journal-title":"Infect. Immun."},{"key":"BFnrgastro2011174_CR79","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/infdis\/163.6.1235","volume":"163","author":"J Clemens","year":"1991","unstructured":"Clemens, J.  et al. Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera. J. Infect. Dis. 163, 1235\u20131242 (1991).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR80","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(86)91944-6","volume":"2","author":"JD Clemens","year":"1986","unstructured":"Clemens, J. D.  et al. Field trial of oral cholera vaccines in Bangladesh. Lancet 2, 124\u2013127 (1986).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR81","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/0264-410X(95)00122-H","volume":"14","author":"FP van Loon","year":"1996","unstructured":"van Loon, F. P.  et al. Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up. Vaccine 14, 162\u2013166 (1996).","journal-title":"Vaccine"},{"key":"BFnrgastro2011174_CR82","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","volume":"335","author":"J Clemens","year":"1990","unstructured":"Clemens, J.  et al. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 335, 270\u2013273 (1990).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR83","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0140-6736(88)92189-7","volume":"2","author":"JD Clemens","year":"1988","unstructured":"Clemens, J. D.  et al. Impact of B subunit killed whole cell and killed whole cell only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera. Lancet 2, 1375\u20131378 (1988).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR84","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(94)90755-2","volume":"344","author":"JL Sanchez","year":"1994","unstructured":"Sanchez, J. L.  et al. Protective efficacy of oral whole-cell\/recombinant-B subunit cholera vaccine in Peruvian military recruits. Lancet 344, 1273\u20131276 (1994).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR85","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1086\/315462","volume":"181","author":"DN Taylor","year":"2000","unstructured":"Taylor, D. N.  et al. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru. J. Infect. Dis. 181, 1667\u20131673 (2000).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR86","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1086\/319673","volume":"183","author":"J Clemens","year":"2001","unstructured":"Clemens, J., Sack, D. & Ivanoff, B. Misleading negative findings in a field trial of killed, oral cholera vaccine in Peru. J. Infect. Dis. 183, 1306\u20131308 (2001).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR87","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/00002030-199406000-00009","volume":"8","author":"DJ Lewis","year":"1994","unstructured":"Lewis, D. J.  et al. Immune response following oral administration of cholera toxin B subunit to HIV-1-infected UK and Kenyan subjects. AIDS 8, 779\u2013785 (1994).","journal-title":"AIDS"},{"key":"BFnrgastro2011174_CR88","doi-asserted-by":"publisher","first-page":"F145","DOI":"10.1097\/00002030-199814000-00001","volume":"12","author":"MB Ortig\u00e3o-de-Sampaio","year":"1998","unstructured":"Ortig\u00e3o-de-Sampaio, M. B.  et al. Increase in plasma viral load oral cholera immunization of HIV-infected subjects. AIDS 12, F145\u2013F150 (1998).","journal-title":"AIDS"},{"key":"BFnrgastro2011174_CR89","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJMoa043323","volume":"352","author":"ME Lucas","year":"2005","unstructured":"Lucas, M. E.  et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N. Engl. J. Med. 352, 757\u2013767 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2011174_CR90","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ijmm.2007.01.009","volume":"297","author":"M Ansaruzzaman","year":"2007","unstructured":"Ansaruzzaman, M.  et al. Genetic diversity of El Tor strains of V. cholerae O1 with hybrid traits isolated from Bangladesh and Mozambique. Int. J. Med. Microbiol. 297, 443\u2013449 (2007).","journal-title":"Int. J. Med. Microbiol."},{"key":"BFnrgastro2011174_CR91","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","volume":"349","author":"DD Trach","year":"1997","unstructured":"Trach, D. D.  et al. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. Lancet 349, 231\u2013235 (1997).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR92","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1016\/j.vaccine.2006.03.008","volume":"24","author":"VD Thiem","year":"2006","unstructured":"Thiem, V. D.  et al. Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam. Vaccine 24, 4297\u20134303 (2006).","journal-title":"Vaccine"},{"key":"BFnrgastro2011174_CR93","doi-asserted-by":"publisher","first-page":"e1006","DOI":"10.1371\/journal.pntd.0001006","volume":"5","author":"DD Anh","year":"2011","unstructured":"Anh, D. D.  et al. Use of oral cholera vaccines in an outbreak in Vietnam: a case\u2013control study. PLoS Negl. Trop. Dis. 5, e1006 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"BFnrgastro2011174_CR94","first-page":"2","volume":"80","author":"DD Trach","year":"2002","unstructured":"Trach, D. D.  et al. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam. Bull. World Health Organ. 80, 2\u20138 (2002).","journal-title":"Bull. World Health Organ."},{"key":"BFnrgastro2011174_CR95","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4161\/hv.4.2.5122","volume":"4","author":"Al Lopez","year":"2008","unstructured":"Lopez, A. l., Clemens, J., Deen, J. & Jodar, L. Cholera vaccines for the developing world. Hum. Vaccines 4, 165\u2013169 (2008).","journal-title":"Hum. Vaccines"},{"key":"BFnrgastro2011174_CR96","unstructured":"World Health Organization Expert Committee on Biological Standardization. Guidelines for the production and control of inactivated oral cholera vaccines. WHO Technical Report Series 924, 129\u2013149 (2004)."},{"key":"BFnrgastro2011174_CR97","first-page":"277","volume":"38","author":"AS Benenson","year":"1968","unstructured":"Benenson, A. S., Saad, A. & Mosley, W. H. Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique. Bull. World Health Organ. 38, 277\u2013285 (1968).","journal-title":"Bull. World Health Organ."},{"key":"BFnrgastro2011174_CR98","first-page":"777","volume":"38","author":"WH Mosley","year":"1968","unstructured":"Mosley, W. H., Ahmad, S., Benenson, A. S. & Ahmed, A. The relationship of vibriocidal antibody titer to susceptibility of cholera in family contacts of cholera patients. Bull. World Health Organ. 38, 777\u2013785 (1968).","journal-title":"Bull. World Health Organ."},{"key":"BFnrgastro2011174_CR99","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","volume":"25","author":"DD Anh","year":"2007","unstructured":"Anh, D. D.  et al. Safety and immunogenicity if a reformulated, Vietnamese, bivalent, killed whole cell, oral cholera vaccine in adults. Vaccine 25, 1149\u20131155 (2007).","journal-title":"Vaccine"},{"key":"BFnrgastro2011174_CR100","doi-asserted-by":"publisher","first-page":"e2323","DOI":"10.1371\/journal.pone.0002323","volume":"3","author":"D Mahanalabis","year":"2008","unstructured":"Mahanalabis, D.  et al. A randomized, placebo-controlled trial of the bivalent killed, whole-cell cholera vaccine in adults and children in a cholera-endemic area in Kolkata, India. PLoS ONE 3, e2323 (2008).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2011174_CR101","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","volume":"374","author":"D Sur","year":"2009","unstructured":"Sur, D.  et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet 374, 1694\u20131702 (2009).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR102","unstructured":"Sur, D.  et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow up of a cluster-randomized, placebo-controlled trial. PLoS Negl. Trop. Dis. (in press)."},{"key":"BFnrgastro2011174_CR103","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0923-2508(90)90128-D","volume":"141","author":"JB Kaper","year":"1990","unstructured":"Kaper, J. B. & Levine, M. M. Recombinant attenuated Vibrio cholerae strains used as live oral vaccines. Res. Microbiol. 141, 901\u2013906 (1990).","journal-title":"Res. Microbiol."},{"key":"BFnrgastro2011174_CR104","first-page":"237","volume":"84","author":"SJ Cryz Jr","year":"1995","unstructured":"Cryz, S. J. Jr, Kaper, J., Tacket, C., Nataro, J. & Levine, M. M. Vibrio cholerae CVD103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effects. Dev. Biol. Stand. 84, 237\u2013244 (1995).","journal-title":"Dev. Biol. Stand."},{"key":"BFnrgastro2011174_CR105","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1086\/315051","volume":"180","author":"R Lagos","year":"1999","unstructured":"Lagos, R.  et al. Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR. J. Infect. Dis. 180, 1700\u20131712 (1999).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR106","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1128\/IAI.67.12.6341-6345.1999","volume":"67","author":"CO Tacket","year":"1999","unstructured":"Tacket, C. O.  et al. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba three months after vaccination. Infect. Immun. 67, 6341\u20136345 (1999).","journal-title":"Infect. Immun."},{"key":"BFnrgastro2011174_CR107","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/0140-6736(92)92231-4","volume":"340","author":"W Suharyono","year":"1992","unstructured":"Suharyono, W.  et al. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5\u20139-year-old Indonesian children. Lancet 340, 689\u2013694 (1992).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR108","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/infdis\/165.6.1042","volume":"165","author":"P Su-Arehawaratana","year":"1992","unstructured":"Su-Arehawaratana, P.  et al. Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand. J. Infect. Dis. 165, 1042\u20131048 (1992).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR109","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/infdis\/166.4.837","volume":"166","author":"CO Tacket","year":"1992","unstructured":"Tacket, C. O.  et al. Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J. Infect. Dis. 166, 837\u2013841 (1992).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR110","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0140-6736(88)90120-1","volume":"1","author":"MM Levine","year":"1988","unstructured":"Levine, M. M.  et al. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet 1, 467\u2013470 (1988).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR111","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","volume":"18","author":"EE Richie","year":"2000","unstructured":"Richie, E. E.  et al. Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine 18, 2399\u20132410 (2000).","journal-title":"Vaccine"},{"key":"BFnrgastro2011174_CR112","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1016\/j.vaccine.2003.11.070","volume":"22","author":"P Calain","year":"2004","unstructured":"Calain, P.  et al. Can oral cholera vaccination play a role in controlling a cholera outbreak? Vaccine 22, 2444\u20132451 (2004).","journal-title":"Vaccine"},{"key":"BFnrgastro2011174_CR113","first-page":"63","volume":"76","author":"RT Perry","year":"1998","unstructured":"Perry, R. T.  et al. A single dose of live oral cholera vaccine CVD 103Hg-R is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali. Bull. World Health Organ. 76, 63\u201371 (1998).","journal-title":"Bull. World Health Organ."},{"key":"BFnrgastro2011174_CR114","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","volume":"366","author":"M Ali","year":"2005","unstructured":"Ali, M.  et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 366, 44\u201349 (2005).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR115","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/INF.0b013e318149dffd","volume":"27","author":"M Ali","year":"2008","unstructured":"Ali, M.  et al. Vaccine protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission. Pediatr. Infect. Dis. J. 27, 33\u201337 (2008).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"BFnrgastro2011174_CR116","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.1371\/journal.pmed.0040336","volume":"4","author":"IM Longini Jr","year":"2007","unstructured":"Longini, I. M. Jr  et al. Controlling endemic cholera with oral vaccines. PLoS Med. 4, e336 (2007).","journal-title":"PLoS Med."},{"key":"BFnrgastro2011174_CR117","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1524-4733.2009.00562.x","volume":"12","author":"M Jeuland","year":"2009","unstructured":"Jeuland, M.  et al. Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis. Value in Health 12, 899\u2013908 (2009).","journal-title":"Value in Health"},{"key":"BFnrgastro2011174_CR118","first-page":"304","volume":"21","author":"DT Vu","year":"2003","unstructured":"Vu, D. T.  et al. Coverage and costs of a mass immunization of an oral cholera vaccine in Vietnam. J. Health Pop. Nutr. 21, 304\u2013308 (2003).","journal-title":"J. Health Pop. Nutr."},{"key":"BFnrgastro2011174_CR119","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.1016\/j.vaccine.2005.10.006","volume":"24","author":"P Cavailler","year":"2006","unstructured":"Cavailler, P.  et al. Feasibility of a mass vaccination campaign using a two dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique. Vaccine 24, 4890\u20134895 (2006).","journal-title":"Vaccine"},{"key":"BFnrgastro2011174_CR120","first-page":"949","volume":"77","author":"F Dorlencourt","year":"1999","unstructured":"Dorlencourt, F.  et al. Effectiveness of mass vaccination with WC\/rBS cholera vaccine during an epidemic in Adjumani district, Uganda. Bull. World Health Organ. 77, 949\u2013950 (1999).","journal-title":"Bull. World Health Organ."},{"key":"BFnrgastro2011174_CR121","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1073\/pnas.1102149108","volume":"108","author":"DL Chao","year":"2011","unstructured":"Chao, D. L., Halloran, M. E. & Longini, I. M. Jr. Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proc. Natl Acad. Sci. USA 108, 7081\u20137085 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2011174_CR122","doi-asserted-by":"publisher","first-page":"e952","DOI":"10.1371\/journal.pntd.0000952","volume":"5","author":"R Reyburn","year":"2011","unstructured":"Reyburn, R.  et al. The case for reactive mass oral cholera vaccinations. PLoS Negl. Trop. Dis. 5, e952 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"BFnrgastro2011174_CR123","unstructured":"World Health Organization. Cholera vaccines: position paper. Weekly Epidemiological Record. 85, 117\u2013128 (2010)."},{"key":"BFnrgastro2011174_CR124","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1086\/514025","volume":"176","author":"DA Sack","year":"1997","unstructured":"Sack, D. A.  et al. Evaluation of Peru-15, a new live oral vaccine for cholera, in volunteers. J. Infect. Dis. 176, 201\u2013205 (1997).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR125","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1128\/IAI.70.4.1965-1970.2002","volume":"70","author":"MB Cohen","year":"2002","unstructured":"Cohen, M. B.  et al. Randomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine. Infect. Immun. 70, 1965\u20131970 (2002).","journal-title":"Infect. Immun."},{"key":"BFnrgastro2011174_CR126","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1086\/432074","volume":"192","author":"F Qadri","year":"2005","unstructured":"Qadri, F.  et al. Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh. J. Infect. Dis. 192, 573\u2013579 (2005).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR127","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.vaccine.2006.08.031","volume":"25","author":"F Qadri","year":"2007","unstructured":"Qadri, F.  et al. Peru-15, a live-attenuated oral cholera vaccine is safe and immunogenic in Bangladeshi toddlers and infants. Vaccine 25, 231\u2013238 (2007).","journal-title":"Vaccine"},{"key":"BFnrgastro2011174_CR128","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1128\/IAI.73.5.3018-3024.2005","volume":"73","author":"L Garc\u00eda","year":"2005","unstructured":"Garc\u00eda, L.  et al. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers. Infect. Immun. 73, 3018\u20133024 (2005).","journal-title":"Infect. Immun."},{"key":"BFnrgastro2011174_CR129","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1016\/j.vaccine.2005.07.015","volume":"24","author":"A Talavera","year":"2006","unstructured":"Talavera, A.  et al. Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638. Vaccine 24, 3746\u20133749 (2006).","journal-title":"Vaccine"},{"key":"BFnrgastro2011174_CR130","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.vaccine.2005.09.059","volume":"24","author":"G Liu","year":"2006","unstructured":"Liu, G.  et al. Resistance of the cholera vaccine candidate IEM108 against CTX\u03c6 infection. Vaccine 24, 1749\u20131755 (2006).","journal-title":"Vaccine"},{"key":"BFnrgastro2011174_CR131","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1128\/IAI.71.10.5498-5504.2003","volume":"71","author":"W Liang","year":"2003","unstructured":"Liang, W.  et al. Construction and evaluation of a safe, live, oral Vibrio cholera vaccine candidate, IEM108. Infect. Immun. 71, 5498\u20135504 (2003).","journal-title":"Infect. Immun."},{"key":"BFnrgastro2011174_CR132","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1016\/j.vaccine.2009.05.065","volume":"27","author":"D Mahanalabis","year":"2009","unstructured":"Mahanalabis, D.  et al. Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response. Vaccine 27, 4850\u20134856 (2009).","journal-title":"Vaccine"},{"key":"BFnrgastro2011174_CR133","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(95)90698-3","volume":"345","author":"TS Coster","year":"1995","unstructured":"Coster, T. S.  et al. Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype. Lancet 345, 949\u2013952 (1995).","journal-title":"Lancet"},{"key":"BFnrgastro2011174_CR134","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/infdis\/172.3.883","volume":"172","author":"CO Tacket","year":"1995","unstructured":"Tacket, C. O.  et al. Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. J. Infect. Dis. 172, 883\u2013886 (1995).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2011174_CR135","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/S0264-410X(02)00412-7","volume":"21","author":"T Ledon","year":"2003","unstructured":"Ledon, T.  et al. Construction and characterization of O139 cholera vaccine candidates. Vaccine 21, 1282\u20131291 (2003).","journal-title":"Vaccine"},{"key":"BFnrgastro2011174_CR136","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/IAI.66.7.3095-3099.1998","volume":"66","author":"RK Gupta","year":"1998","unstructured":"Gupta, R. K., Taylor, D. N., Bryla, D. A., Robbins, J. B. & Szu, S. C. Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide\u2013cholera toxin conjugates in adult volunteers. Infect. Immun. 66, 3095\u20133099 (1998).","journal-title":"Infect. Immun."},{"key":"BFnrgastro2011174_CR137","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1128\/IAI.69.5.3488-3493.2001","volume":"69","author":"A Boutonnier","year":"2001","unstructured":"Boutonnier, A., Villeneuve, S., Nato, F., Dassy, B. & Fournier, J. M. Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid. Infect. Immun. 69, 3488\u20133493 (2001).","journal-title":"Infect. Immun."},{"key":"BFnrgastro2011174_CR138","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1128\/IAI.68.9.5037-5043.2000","volume":"68","author":"Z Kossaczka","year":"2000","unstructured":"Kossaczka, Z.  et al. Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice. Infect. Immun. 68, 5037\u20135043 (2000).","journal-title":"Infect. Immun."},{"key":"BFnrgastro2011174_CR139","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1056\/NEJMp1012300","volume":"363","author":"M Waldor","year":"2010","unstructured":"Waldor, M., Hotez, P. & Clemens, J. A national cholera vaccine stockpile\u2014a new humanitarian and diplomatic resource. N. Engl. J. Med. 363, 2279\u20132282 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2011174_CR140","unstructured":"Background paper on the integration of oral cholera vaccines into global cholera control programmes. WHO strategic advisory group of experts (SAGE) on immunization [online], (2009)."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2011.174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2011.174","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2011.174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T12:08:21Z","timestamp":1744373301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2011.174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,8]]},"references-count":140,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["BFnrgastro2011174"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2011.174","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,8]]},"assertion":[{"value":"8 November 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J. D. Clemens has received research support from Shantha Biotechnic. J. Holmgren has provided consultancy services to Crucell, Sweden. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}